A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)

This study has been terminated.

( Based on the data and observed benefit-risk profile, the trial's independent oversight committee recommended that enrollment not resume. )

Study NCT00073372 Information provided by Centocor, Inc.

First Received: November 19, 2003 Last Updated: March 17, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2005
Estimated Primary Completion Date:	No date given